Workflow
Universal Technical Institute: Concorde Deregulation Signals New Upside (NYSE:UTI)
Seeking Alpha· 2025-11-13 23:44
The market still treats Universal Technical Institute ( UTI ) as a traditional vocational school specializing in mechanics and diesel, ignoring the transformation it has made through its acquisitions, such as Concorde Career Colleges, which represents a pivotal pointAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions ...
DT Midstream, Inc. (DTM) Presents at Bank of America Global Energy Conference - Slideshow (NYSE:DTM) 2025-11-13
Seeking Alpha· 2025-11-13 23:43
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Amid Big Media M&A, Starz Seeks “Marooned” Linear Brands To Reposition For Digital
Deadline· 2025-11-13 23:43
CEO Jeff Hirsch said Starz sees a place for itself in the current M&A landscape by picking off linear networks that aren’t valuable to giant owners but could be repositioned to add value to the newly independent company. He has hinted at that before but expanded on a call after quarterly earnings that Starz wants to diversify from pure SVOD (streaming) to AVOD (streaming with ads) but can’t “because of the nature of the adult nature of our content and the amount of content we have” relative to the giant pl ...
DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – DXCM
Businesswire· 2025-11-13 23:43
LOS ANGELES--(BUSINESS WIRE)--DexCom, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – DXCM. ...
Marchex outlines 10% revenue growth and 10%+ EBITDA margin targets for 2026 as Archenia acquisition advances (NASDAQ:MCHX)
Seeking Alpha· 2025-11-13 23:42
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Kainos Group plc 2026 Q2 - Results - Earnings Call Presentation (OTCMKTS:KNNNF) 2025-11-13
Seeking Alpha· 2025-11-13 23:42
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation - AGL
Newsfile· 2025-11-13 23:42
New York, New York--(Newsfile Corp. - November 13, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the investing public.SO WHAT: If you purchased agilon health securities you may be entitled to compensation without payment of any out of pocket fees or costs through a ...
PPL Corporation (PPL) Presents at EEI Financial Conference - Slideshow (NYSE:PPL) 2025-11-13
Seeking Alpha· 2025-11-13 23:41
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
Biogen Inc. (BIIB) Presents at TD Cowen Immunology and Inflammation Summit Transcript
Seeking Alpha· 2025-11-13 23:41
Group 1 - Biogen has reinvigorated its Immunology and Inflammation (I&I) efforts, indicating a strategic shift beyond its historical focus on neuroscience [1] - The company's expertise in neuro-immunology, particularly in the central nervous system (CNS), underpins its strategy in I&I and kidney areas [1] - Biogen has been involved in lupus research for over a decade, highlighting its long-term commitment to immunological pathways [2] Group 2 - The development of drugs targeting immunological pathways is aimed at supporting a diverse product portfolio [2]
Nortech Systems Incorporated (NSYS) Q3 2025 Earnings Call Prepared Remarks Transcript
Seeking Alpha· 2025-11-13 23:41
Core Viewpoint - Nortech Systems, Inc. is conducting its Third Quarter 2025 Earnings Conference Call to discuss operational reviews, recent developments, and financial results [1][2]. Group 1: Operational Overview - The call will begin with a review of operations and business outlook by the President and CEO, Jay Miller [2]. - The company emphasizes that statements made during the call may include forward-looking information regarding expected net sales and operating results [2][3]. Group 2: Financial Results - The Chief Financial Officer, Andrew LaFrence, will present the financial results for the third quarter of 2025 following the operational review [2]. - The company will provide insights into future plans and opportunities during the call [2].